CNPY2 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
fibroblast	22 studies	28% ± 13%	Explore
endothelial cell	19 studies	29% ± 14%	Explore
natural killer cell	18 studies	23% ± 4%	Explore
pericyte	14 studies	23% ± 8%	Explore
plasma cell	14 studies	36% ± 15%	Explore
endothelial cell of lymphatic vessel	11 studies	31% ± 12%	Explore
smooth muscle cell	11 studies	22% ± 6%	Explore
connective tissue cell	10 studies	30% ± 12%	Explore
epithelial cell	10 studies	40% ± 24%	Explore
basal cell	10 studies	29% ± 16%	Explore
T cell	9 studies	22% ± 11%	Explore
B cell	8 studies	22% ± 8%	Explore
CD4-positive, alpha-beta T cell	8 studies	20% ± 3%	Explore
oligodendrocyte precursor cell	8 studies	32% ± 13%	Explore
mature NK T cell	7 studies	19% ± 2%	Explore
gamma-delta T cell	7 studies	25% ± 11%	Explore
ciliated cell	7 studies	37% ± 15%	Explore
non-classical monocyte	6 studies	21% ± 8%	Explore
CD8-positive, alpha-beta T cell	6 studies	23% ± 3%	Explore
plasmablast	6 studies	44% ± 11%	Explore
myofibroblast cell	6 studies	29% ± 5%	Explore
abnormal cell	6 studies	33% ± 13%	Explore
goblet cell	6 studies	30% ± 15%	Explore
regulatory T cell	6 studies	17% ± 1%	Explore
oligodendrocyte	6 studies	22% ± 5%	Explore
conventional dendritic cell	5 studies	28% ± 11%	Explore
capillary endothelial cell	5 studies	21% ± 2%	Explore
progenitor cell	5 studies	30% ± 7%	Explore
macrophage	5 studies	23% ± 7%	Explore
intestinal crypt stem cell	5 studies	26% ± 8%	Explore
endothelial cell of vascular tree	5 studies	20% ± 3%	Explore
astrocyte	5 studies	26% ± 12%	Explore
mast cell	5 studies	19% ± 3%	Explore
secretory cell	5 studies	28% ± 10%	Explore
plasmacytoid dendritic cell	5 studies	20% ± 5%	Explore
pancreatic A cell	4 studies	70% ± 11%	Explore
type B pancreatic cell	4 studies	61% ± 15%	Explore
leukocyte	4 studies	21% ± 5%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	21% ± 3%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	23% ± 5%	Explore
CD16-negative, CD56-bright natural killer cell, human	4 studies	27% ± 5%	Explore
CD16-positive, CD56-dim natural killer cell, human	4 studies	25% ± 2%	Explore
classical monocyte	4 studies	26% ± 9%	Explore
kidney loop of Henle epithelial cell	4 studies	23% ± 4%	Explore
epithelial cell of proximal tubule	4 studies	28% ± 17%	Explore
endothelial cell of artery	4 studies	33% ± 8%	Explore
enterocyte	4 studies	23% ± 7%	Explore
enteroendocrine cell	4 studies	42% ± 19%	Explore
vein endothelial cell	4 studies	26% ± 7%	Explore
IgG plasma cell	4 studies	28% ± 9%	Explore
transit amplifying cell	4 studies	19% ± 3%	Explore
type II pneumocyte	4 studies	33% ± 23%	Explore
innate lymphoid cell	4 studies	18% ± 2%	Explore
neuron	4 studies	42% ± 16%	Explore
pancreatic D cell	3 studies	62% ± 17%	Explore
naive B cell	3 studies	19% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell	3 studies	22% ± 4%	Explore
hematopoietic precursor cell	3 studies	38% ± 15%	Explore
glomerular endothelial cell	3 studies	22% ± 3%	Explore
kidney distal convoluted tubule epithelial cell	3 studies	46% ± 11%	Explore
mesothelial cell	3 studies	39% ± 19%	Explore
neural crest cell	3 studies	53% ± 19%	Explore
IgA plasma cell	3 studies	29% ± 7%	Explore
retinal bipolar neuron	3 studies	31% ± 10%	Explore
extravillous trophoblast	3 studies	66% ± 10%	Explore
placental villous trophoblast	3 studies	63% ± 21%	Explore
common myeloid progenitor	3 studies	25% ± 6%	Explore
hematopoietic stem cell	3 studies	21% ± 6%	Explore
lymphocyte	3 studies	25% ± 10%	Explore
mucosal invariant T cell	3 studies	18% ± 2%	Explore
myeloid cell	3 studies	25% ± 11%	Explore
brush cell	3 studies	31% ± 10%	Explore
club cell	3 studies	20% ± 5%	Explore
amacrine cell	3 studies	40% ± 13%	Explore
retina horizontal cell	3 studies	28% ± 15%	Explore
Mueller cell	3 studies	21% ± 6%	Explore
erythroblast	3 studies	29% ± 16%	Explore
luminal cell of prostate epithelium	3 studies	23% ± 4%	Explore
IgM plasma cell	3 studies	29% ± 11%	Explore
type I pneumocyte	3 studies	28% ± 14%	Explore
dendritic cell	3 studies	34% ± 15%	Explore
pancreatic ductal cell	3 studies	52% ± 11%	Explore
T follicular helper cell	3 studies	17% ± 1%	Explore
T-helper 17 cell	3 studies	20% ± 2%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
intestine	8 studies	27% ± 14%	Explore
lung	8 studies	30% ± 12%	Explore
peripheral blood	7 studies	24% ± 5%	Explore
brain	6 studies	33% ± 14%	Explore
kidney	5 studies	24% ± 6%	Explore
pancreas	4 studies	59% ± 20%	Explore
eye	4 studies	26% ± 11%	Explore
uterus	4 studies	27% ± 13%	Explore
placenta	3 studies	46% ± 21%	Explore
liver	3 studies	30% ± 17%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
ovary	100%	2714.25	180 / 180	100%	8.51	430 / 430
prostate	100%	2746.18	245 / 245	100%	4.54	502 / 502
esophagus	100%	1886.08	1444 / 1445	100%	5.68	183 / 183
brain	100%	2051.69	2640 / 2642	100%	4.87	705 / 705
stomach	100%	2171.21	359 / 359	100%	5.84	285 / 286
intestine	100%	2158.42	966 / 966	100%	5.34	525 / 527
breast	100%	2340.31	459 / 459	99%	3.52	1112 / 1118
pancreas	100%	2333.01	328 / 328	99%	3.30	177 / 178
thymus	100%	3407.44	653 / 653	99%	3.46	600 / 605
adrenal gland	100%	3464.68	258 / 258	99%	4.03	228 / 230
uterus	100%	2435.88	170 / 170	99%	3.55	453 / 459
bladder	100%	2151.67	21 / 21	98%	4.36	496 / 504
lung	100%	2126.29	576 / 578	98%	3.64	1134 / 1155
skin	100%	2181.86	1808 / 1809	96%	3.63	454 / 472
liver	100%	2795.31	226 / 226	96%	2.83	389 / 406
kidney	100%	2479.66	89 / 89	95%	2.87	854 / 901
adipose	100%	2041.91	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	2.50	29 / 29
spleen	100%	2426.11	241 / 241	0%	0	0 / 0
ureter	0%	0	0 / 0	100%	6.10	1 / 1
blood vessel	100%	2281.40	1334 / 1335	0%	0	0 / 0
heart	98%	1213.56	840 / 861	0%	0	0 / 0
muscle	97%	865.36	775 / 803	0%	0	0 / 0
eye	0%	0	0 / 0	96%	2.82	77 / 80
tonsil	0%	0	0 / 0	91%	1.91	41 / 45
peripheral blood	77%	991.21	711 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

IV. Literature review

[source]

Gene name	CNPY2
Protein name	Canopy FGF signaling regulator 2 Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4)
Synonyms	TMEM4 UNQ1943/PRO4426 ZSIG9 MSAP
Description	FUNCTION: Positive regulator of neurite outgrowth by stabilizing myosin regulatory light chain (MRLC). It prevents MIR-mediated MRLC ubiquitination and its subsequent proteasomal degradation.
Accessions	ENST00000546466.5 ENST00000551286.1 H0YIH9 Q9Y2B0 H0YI18 ENST00000551475.5 F8VXJ7 ENST00000553191.1 ENST00000273308.9 [Q9Y2B0-1] F8W1K5

GO_0010629	Biological process	negative regulation of gene expression
GO_0010988	Biological process	regulation of low-density lipoprotein particle clearance
GO_1905599	Biological process	positive regulation of low-density lipoprotein receptor activity
GO_0005783	Cellular component	endoplasmic reticulum
GO_0005515	Molecular function	protein binding

CNPY2 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review